Autism Spectrum Disorder Trial, Recruiting NCT07032857 Sponsor: University of Bari Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT07032857
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children who have been diagnosed with Autism Spectrum Disorder (ASD) based on recognised clinical standards, with that diagnosis confirmed by a specific assessment tool called the ADOS-G.
  • Children who regularly eat foods that contain gluten (such as bread, pasta, and cereals).
  • Children whose blood tests show no signs of coeliac disease (specifically, certain antibody tests must come back negative).
  • Children who have no known food allergies, whether immediate (such as anaphylaxis-type reactions) or delayed (such as intolerances involving the immune system).

Who may not be able to join:

  • Children who have a known neurological condition (a condition affecting the brain or nervous system).
  • Children who were born with major physical abnormalities or structural differences present from birth.
  • Children who have experienced a severe head injury.
  • Children who have a long-term or ongoing digestive or gut condition.
  • Children who are already following a special diet, such as a gluten-free diet or a diet that removes both gluten and casein (a protein found in dairy).
  • Children who have taken antibiotics, probiotics, or prebiotics within the four weeks before joining the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 00390805592063

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Bari
Registry
ClinicalTrials.gov
Start date
1 January 2023
Est. completion
30 September 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

intestinal permeability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov